Mapi-Pharma sets IPO range

Mapi-Pharma Ltd. (Ness Ziona, Israel) amended its IPO on NASDAQ and now plans to sell 2.9 million shares at $13-$15. At the $14 midpoint, the company would raise $40 million and be valued at $215 million. Aegis Capital is underwriter. Mapi-Pharma filed to raise up to $46 million in the offering last month. ...